---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-008464"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2024-12-03T23:59:59+00:00"
generated_at: "2026-05-29T09:56:35.759050+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# CNS Pharma stockholders approve reverse split (1:2 to 1:50) and warrant repricing

## Summary
- Reverse split authorized at ratio between 1-for-2 and 1-for-50; passed with 7,873,677 votes for, 3,121,776 against, 314,908 abstain.
- Warrant repricing approved: new exercise price lower of $1.13 per share or closing price on approval date; 1,458,915 for, 1,106,009 against, 171,894 abstain.
- Adjournment authorization passed: 8,022,415 for, 2,904,712 against, 383,234 abstain.
- Meeting held Nov 26, 2024; quorum of 11,310,361 shares (33.82% of 33,446,403 outstanding) present.

## SEC filing metadata
- accession: 0001683168-24-008464
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2024-12-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316824008464/0001683168-24-008464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824008464/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-008464
- JSON: https://secwatch.observer/filing/0001683168-24-008464.json
- Plain text: https://secwatch.observer/filing/0001683168-24-008464.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.